KLRA
Kailera Therapeutics, Inc.
Set alert
12.86 USD -0.55 -4.10%
12.54 Day range 13.40
10.00 52-week range 26.00
- YTD
- -50.54%
- 1 year
- -50.54%
- Open
- 13.27
- Prev close
- 13.41
- Mkt cap
- 1.67B
- Vol
- 868.43K
- Avg vol
- 1.02M
- EPS
- -4.51
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 12.54
- High
- 13.40
- Forward P/E
- -2.99
- Beta
- 0.00
- Short ratio
- 5.58
- Inst. own
- 90.55%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 4, 2026
- 50-d avg
- 13.39
- 200-d avg
- 18.01
- 1y target
- 42.75
Financial health
FMP rating
C+2 / 5 overall
- DCF 2
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 4
- P/E 1
- P/B 3
Valuation
P/E -20.6×
FY 2025 5y median -20.6× FY 2025
P/S 0.0×
FY 2025 5y median 0.0× FY 2025
P/B -8.6×
FY 2025 5y median -8.6× FY 2025
P/FCF -25.1×
FY 2025 5y median -25.1× FY 2025
EV/EBITDA -18.5×
FY 2025 5y median -18.5× FY 2025
EV/Sales 0.0×
FY 2025 5y median 0.0× FY 2025
FCF Yield -4.0%
FY 2025 5y median -4.0% FY 2025
Profitability
Gross Margin 0.0%
FY 2025 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2025 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2025 5y median 0.0% FY 2025
ROE 41.8%
FY 2025 5y median 41.8% FY 2025
ROIC -24.5%
FY 2025 5y median -24.5% FY 2025
ROA -21.5%
FY 2025 5y median -21.5% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2025 FY 2025
Operating Income 0.0%
FY 2025 FY 2025
EPS (diluted) 0.0%
FY 2025 FY 2025
Free Cash Flow 0.0%
FY 2025 FY 2025
Financial Health
Current Ratio 12.0×
FY 2025 5y median 12.0× FY 2025
Quick Ratio 12.0×
FY 2025 5y median 12.0× FY 2025
Debt / Equity -0.0×
FY 2025 5y median -0.0× FY 2025
Net Debt / EBITDA 0.9×
FY 2025 5y median 0.9× FY 2025
Interest Coverage 0.0×
FY 2025 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2025 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2025 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31